Monitoring the Retention of a Protein Antigen in Complete Freund's Adjuvant, Alum, and Pluronic F-127 Gel Formulations by X-ray Fluorescence
- 1 January 2001
- journal article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 6 (2) , 241-246
- https://doi.org/10.1081/pdt-100002200
Abstract
Adjuvants function by protecting antigens from rapid degradation or dispersal. The effectiveness of experimental adjuvants can be assessed by measuring antibody titers to the antigen of interest or, less frequently, by evaluating the retention and distribution of antigen at the application site. In this study, we used X-ray fluorescence (XRF) to monitor the release of an iodinated protein (I-bovine serum albumin) from several adjuvant formulations after its subcutaneous injection in rats. The interaction of the tagged antigen with an external Am-241 source leads to the emission of iodine X-rays from the application site; the number of these X-rays is proportional to the concentration of the protein remaining at the injection site. The disappearance of the iodine X-rays, and hence the antigen, from the injection site followed first-order kinetics for all adjuvant formulations tested; mean half-life values were as follows: in 50% Freund's adjuvant, 17.1 ± 1.1 h; in 4-hour-old 25% Alum, 11.78 ± 0.08 h; in 4-...Keywords
This publication has 21 references indexed in Scilit:
- Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in ratsInternational Journal of Pharmaceutics, 1999
- Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptideVaccine, 1999
- Evaluation of Pluronic F127-Based Sustained-Release Ocular Delivery Systems for Pilocarpine using the Albino Rabbit Eye ModelJournal of Pharmaceutical Sciences, 1998
- Pluronid® F-68 Inhibits Agonist-Induced Platelet Aggregation in Human Whole Blood in VitroArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1998
- Secondary x-ray fluorescence for in vivo transdermal absorption measurementsInternational Journal of Pharmaceutics, 1996
- Hemopoietic Growth and Inhibitory Factors in Treatment of Malignancies: A reviewActa Oncologica, 1995
- Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: A possible immunoregulatory role of tumor necrosis factor in the prevention of diabetesClinical Immunology and Immunopathology, 1992
- Alpha interferon: The potential drug of adjuvant therapy: Past achievements and future challengesEuropean Journal of Cancer and Clinical Oncology, 1991
- Adjuvant Activity of Saponin: Antigen Localization StudiesInternational Archives of Allergy and Immunology, 1985
- Adjuvant actions of polyclonal lymphocyte activatorsCellular Immunology, 1981